Nocturnal oxygen therapy as an option for early COVID-19

There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Chongxing, Yue, Xiaofeng, Wang, Jianwu, Shi, Chunmeng, Li, Weibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319633/
https://www.ncbi.nlm.nih.gov/pubmed/32599285
http://dx.doi.org/10.1016/j.ijid.2020.06.080
_version_ 1783551095008657408
author Shen, Chongxing
Yue, Xiaofeng
Wang, Jianwu
Shi, Chunmeng
Li, Weibing
author_facet Shen, Chongxing
Yue, Xiaofeng
Wang, Jianwu
Shi, Chunmeng
Li, Weibing
author_sort Shen, Chongxing
collection PubMed
description There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability.
format Online
Article
Text
id pubmed-7319633
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-73196332020-06-29 Nocturnal oxygen therapy as an option for early COVID-19 Shen, Chongxing Yue, Xiaofeng Wang, Jianwu Shi, Chunmeng Li, Weibing Int J Infect Dis Perspective There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020-09 2020-06-26 /pmc/articles/PMC7319633/ /pubmed/32599285 http://dx.doi.org/10.1016/j.ijid.2020.06.080 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Perspective
Shen, Chongxing
Yue, Xiaofeng
Wang, Jianwu
Shi, Chunmeng
Li, Weibing
Nocturnal oxygen therapy as an option for early COVID-19
title Nocturnal oxygen therapy as an option for early COVID-19
title_full Nocturnal oxygen therapy as an option for early COVID-19
title_fullStr Nocturnal oxygen therapy as an option for early COVID-19
title_full_unstemmed Nocturnal oxygen therapy as an option for early COVID-19
title_short Nocturnal oxygen therapy as an option for early COVID-19
title_sort nocturnal oxygen therapy as an option for early covid-19
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319633/
https://www.ncbi.nlm.nih.gov/pubmed/32599285
http://dx.doi.org/10.1016/j.ijid.2020.06.080
work_keys_str_mv AT shenchongxing nocturnaloxygentherapyasanoptionforearlycovid19
AT yuexiaofeng nocturnaloxygentherapyasanoptionforearlycovid19
AT wangjianwu nocturnaloxygentherapyasanoptionforearlycovid19
AT shichunmeng nocturnaloxygentherapyasanoptionforearlycovid19
AT liweibing nocturnaloxygentherapyasanoptionforearlycovid19

Ejemplares similares